Endoscopic Variceal Ligation plus Propranolol vs. Transjugular Intrahepatic Portosystemic Stent Shunt: A Long-Term Randomized Trial

 

 Buy Article Permissions and Reprints

Background and Study Aims: After a first variceal bleeding episode in patients with cirrhosis of the liver, treatment with transjugular intrahepatic portosystemic stent shunt (TIPS) and endoscopic variceal ligation (EVL) plus propranolol were compared, with regard to prevention of variceal rebleeding, complications, and mortality.
Patients and Methods: 85 patients were randomly allocated to receive TIPS (n = 43) or EVL (n = 42). The groups were comparable regarding age, sex, etiology of liver cirrhosis, and liver function.
Results: The mean observation times were 4.1 years in the TIPS group and 3.6 years in the EVL group. Although the probability of rebleeding was higher in the EVL group (29.9 %) than in the TIPS group (19.4 %), the difference was not statistically significant. Three of five patients of the EVL group successfully underwent TIPS placement after treatment failure. The probability of TIPS dysfunction requiring shunt revision was 89 %. Hepatic encephalopathy was observed more often in the TIPS group (40.5 %) than in the EVL group (20.5 %; P < 0.05). The probability of survival was similar in both groups (TIPS group 75.9 %, EVL group 82.2 %; n.s.).
Conclusions: In view of its good efficacy and the lower cost of treatment, endoscopic ligation plus propranolol may be recommended as initial procedure for prevention of recurrent variceal hemorrhage, whereas TIPS seems to be the preferable procedure in patients with recurrent bleeding after adequate endoscopic and pharmacological treatment.

References

• 1 Bosch J. Medical treatment of portal hypertension.  Digestion. 1998;  59 547-555
  CrossrefPubMedGoogle Scholar
• 2 D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review.  Hepatology. 1995;  22 332-354
  CrossrefPubMedGoogle Scholar
• 3 Bosch J, Garcia-Pagan J C, Feu F, Rodes J. Portal hypertension: Clinical pathobiology. In: Arias IM, Boyer JL, Fausto N, et al. (eds) The liver: Biology and pathobiology. New York; Raven Press 1994: 1343-1355
  Google Scholar
• 4 Stiegmann G V, Goff J S, Michaletz-Onody P A. et al . Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.  N Engl J Med. 1992;  326 1521-1527
  PubMedGoogle Scholar
• 5 Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis.  Ann Intern Med. 1995;  123 280-287
  PubMedGoogle Scholar
• 6 Sarin S K, Govil A, Jain A K. et al . Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence.  J Hepatol. 1997;  26 826-832
  CrossrefPubMedGoogle Scholar
• 7 Avgerinos A, Armonis A, Manolakopoulos S. et al . Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study.  J Hepatol. 1997;  26 1034-1041
  CrossrefPubMedGoogle Scholar
• 8 Baroncini D, Milandri G L, Borioni D. et al . A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.  Endoscopy. 1997;  29 235-240
  PubMedGoogle Scholar
• 9 Sanyal A J, Freedman A M, Purdum P P. et al . Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: A randomized prospective trial.  Ann Intern Med. 1997;  126 849-857
  PubMedGoogle Scholar
• 10 Cabrera J, Maynar M, Granados R. et al . Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.  Gastroenterology. 1996;  110 832-839
  PubMedGoogle Scholar
• 11 Cello J P, Ring E J, Olcott E W. et al . Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage.  Ann Intern Med. 1997;  126 858-865
  PubMedGoogle Scholar
• 12 Garcia-Villareal L, Martinez-Lagares F, Siebra A. et al . Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.  Hepatology. 1999;  29 27-32
  CrossrefPubMedGoogle Scholar
• 13 Rössle M, Deibert P, Haag K. et al . Randomised trial of transjugular intrahepatic portosystemic stent shunt versus endoscopy plus propranolol for variceal rebleeding.  Lancet. 1997;  349 1043-1049
  CrossrefPubMedGoogle Scholar
• 14 Sauer P, Theilmann L, Stremmel W. et al . Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.  Gastroenterology. 1997;  113 1623-1631
  PubMedGoogle Scholar
• 15 Merli M, Salerno F, Riggio O. et al . Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T).  Hepatology. 1998;  27 48-53
  CrossrefPubMedGoogle Scholar
• 16 Jalan R, Forrest E H, Stanley A J. et al . A randomized trial comparing transjugular intrahepatic porto systemic stent shunt with variceal band ligation in the prevention of rebleeding from esophageal varices.  Hepatology. 1997;  26 1115-1122
  PubMedGoogle Scholar
• 17 Pomier-Layrargues G, Villeneuve J P, Deschenes M. et al . Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: A randomised trial.  Gut. 2001;  48 390-396
  CrossrefPubMedGoogle Scholar
• 18 Papatheodoridis G V, Goulis J, Leandro G. et al . Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.  Hepatology. 1999;  30 612-622
  CrossrefPubMedGoogle Scholar
• 19 Luca A, D'Amico G, LaGalla R. et al . TIPS for prevention of recurrent bleeding in patients with cirrhosis: A meta-analysis of randomized trials.  Radiology. 1999;  212 411-421
  CrossrefPubMedGoogle Scholar
• 20 Tait I S, Krige J EJ, Terblanche J. Endoscopic band ligation of esophageal varices.  Br J Surg. 1999;  86 437-446
  CrossrefPubMedGoogle Scholar
• 21 Richter G M, Noeldge G, Palmaz J C. et al . Transjugular intrahepatic portocaval stent shunt. Preliminary clinical results.  Radiology. 1990;  174 1027-1030
  CrossrefPubMedGoogle Scholar
• 22 DeFranchis R, Pascal J P, Ancona E. et al . Definitions, methodology and therapeutic strategies in portal hypertension.  J Hepatol. 1992;  15 256-261
  CrossrefPubMedGoogle Scholar
• 23 Conn H O. Trailmarking and number connection tests in the assessment of mental state in portal systemic encephalopathy.  Dig Dis. 1977;  22 541-550
  CrossrefPubMedGoogle Scholar
• 24 Merkel M, Morabito A. Adding beta-blockers to sclerotherapy in the prevention of variceal rebleeding. A meta-analysis assessment.  J Hepatol. 1994;  21 918-919
  CrossrefPubMedGoogle Scholar
• 25 Bosch J, Garcia-Pagan J C. Complications of cirrhosis I. Portal hypertension.  J Hepatol. 2000;  32 141-156
  CrossrefPubMedGoogle Scholar
• 26 Lo G H, Lai K H, Cheng J S. et al . Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective randomized trial.  Hepatology. 2000;  32 461-465
  CrossrefPubMedGoogle Scholar
• 27 Merkel C, Bolognesi M, Sacerdoti D. et al . The heodynamic response to medical treatment of portal hypertension as a predictor of clinical effectivness in the primary prophylaxis of variceal bleeding in cirrhosis.  Hepatology. 2000;  32 930-934
  CrossrefPubMedGoogle Scholar
• 28 Bohnacker S, Maydeo A, Soehendra N. Variceal bleeding and portal hypertension: Still a therapeutic challenge.  Endoscopy. 1999;  31 26-37
  Article in Thieme ConnectPubMedGoogle Scholar
• 29 Lo G H, Lai K H, Cheng J S. et al . The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective, randomized trial.  Hepatology. 1998;  28 391-395
  CrossrefPubMedGoogle Scholar
• 30 Djurdjevic D, Janosevic S, Dapcevic B. et al . Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: A randomized and prospective study.  Endoscopy. 1999;  31 286-290
  Article in Thieme ConnectPubMedGoogle Scholar
• 31 Garg P K, Joshi Y K, Tandon R K. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: A prospective randomized study.  Gastrointest Endosc. 1999;  50 369-373
  CrossrefPubMedGoogle Scholar
• 32 Saeed Z A, Stiegmann G V, Ramirez F C. et al . Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial.  Hepatology. 1997;  25 71-74
  CrossrefPubMedGoogle Scholar
• 33 Graham D Y, Smith J L. The course of patients after variceal hemorrhage.  Gastroenterology. 1981;  80 800-809
  CrossrefPubMedGoogle Scholar
• 34 Pagliaro L, D'Amico G, Pasta L. et al .Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann R, editors Portal hypertension: Pathophysiology and treatment. Cambridge, MA; Blackwell Scientific 1994: 72-92
  Google Scholar
• 35 Roessle M, Haag K, Ochs A. et al . The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.  N Engl J Med. 1994;  330 165-171
  CrossrefPubMedGoogle Scholar
• 36 Lind C D, Malisch T W, Chong W K. et al . Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement.  Gastroenterology. 1994;  106 1277-1283
  PubMedGoogle Scholar
• 37 Haskal Z J, Pentecost M J, Soulen M C. et al . Transjugular intrahepatic portosystemic shunt stenosis and revision: Early and midterm results.  AJR Am J Roentgenol. 1994;  192 231-234
  PubMedGoogle Scholar
• 38 Sauer P, Theilmann L, Herrmann S. et al . Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: A randomized trial.  Hepatology. 1996;  24 1433-1436
  PubMedGoogle Scholar
• 39 Richter G M, Noeldge G, Brado M. et al . TIPSS: 10 years of clinical experience.  Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr. 1998;  168 307-315
  PubMedGoogle Scholar
• 40 Hansmann H J, Noldge G, Leutloff U. et al . Radiologic after-care of transjugular intrahepatic stent shunt.  Radiologe. 2001;  41 884-890
  CrossrefPubMedGoogle Scholar

P. Sauer, M.D.

Medizinische Universitätsklinik · Innere Medizin IV

Bergheimer Strasse 58 · 69115 Heidelberg · Germany

Fax: + 49-6221-565687

Email: peter_sauer@med.uni-heidelberg.de